Inactive Instrument

Aker BioMarine AS Stock Oslo Bors

Equities

NO0010886625

Fishing & Farming

Real-time Estimate Cboe Europe 10:20:00 2024-04-26 am EDT 5-day change 1st Jan Change
71.6 NOK -30.21% Intraday chart for Aker BioMarine AS -4.11% -12.68%
Sales 2024 * 4.06B 368M Sales 2025 * 4.55B 413M Capitalization 6.37B 577M
Net income 2024 * -163M -14.78M Net income 2025 * 202M 18.32M EV / Sales 2024 * 2.52 x
Net Debt 2024 * 3.84B 348M Net Debt 2025 * 3.6B 327M EV / Sales 2025 * 2.19 x
P/E ratio 2024 *
24.2 x
P/E ratio 2025 *
30.4 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 13.09%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 48 08-12-31
Director of Finance/CFO 47 18-07-31
Human Resources Officer - 16-04-30
Members of the board TitleAgeSince
Director/Board Member 54 94-12-31
Director/Board Member 64 20-12-31
Chairman 47 13-12-31
More insiders
Aker Biomarine ASA is a Norway-based biotech innovator and Antarctic krill-harvesting company. It consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
Calendar
More about the company